175 related articles for article (PubMed ID: 8833559)
1. Pseudomonas bacteremia precipitated by ticlopidine-induced neutropenia.
Geletko SM; Melbourne KM; Mikolich DJ
Ann Pharmacother; 1996 Mar; 30(3):246-8. PubMed ID: 8833559
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of hospitalized neutropenic oncology patients with Pseudomonas aeruginosa bloodstream infections: focus on oral fluoroquinolone conversion.
Yan LZ; Herrington JD
J Oncol Pharm Pract; 2016 Aug; 22(4):584-90. PubMed ID: 26156260
[TBL] [Abstract][Full Text] [Related]
3. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
Yoshida M; Karasawa M; Naruse T; Fukuda M; Hirashima K; Oh H; Ninomiya H; Abe T; Saito K; Shishido H; Moriyama Y; Shibata A; Motoyoshi K; Nagata N; Miura Y
Int J Hematol; 1999 Feb; 69(2):81-8. PubMed ID: 10071455
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow suppression and klebsiella pneumonia septicemia due to ticlopidine and successful treatment with filgrastim; a case report.
Korkmaz ME; Cekin AH
Int J Cardiol; 1998 Oct; 66(3):317-8. PubMed ID: 9874086
[TBL] [Abstract][Full Text] [Related]
5. Fatal neutropenia and thrombocytopenia associated with ticlopidine.
Carlson JA; Maesner JE
Ann Pharmacother; 1994 Nov; 28(11):1236-8. PubMed ID: 7849334
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte colony stimulating factor treatment for delayed recovery of ticlopidine-related neutropenia.
Hung MJ; Wang CH; Cherng WJ
Int J Clin Pract; 2002; 56(1):70-1. PubMed ID: 11831843
[TBL] [Abstract][Full Text] [Related]
7. Ticlopidine induced agranulocytosis managed with granulocyte colony stimulating factor.
Thomson LE; Stewart JT
N Z Med J; 1998 Mar; 111(1061):81-2. PubMed ID: 9549559
[No Abstract] [Full Text] [Related]
8. Cost effectiveness of pegfilgrastim versus filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma: an economic evaluation of the PALM Trial.
Perrier L; Lefranc A; Pérol D; Quittet P; Schmidt-Tanguy A; Siani C; de Peretti C; Favier B; Biron P; Moreau P; Bay JO; Lissandre S; Jardin F; Espinouse D; Sebban C
Appl Health Econ Health Policy; 2013 Apr; 11(2):129-38. PubMed ID: 23435861
[TBL] [Abstract][Full Text] [Related]
9. Adjunctive efficacy of granulocyte colony-stimulating factor on treatment of Pseudomonas aeruginosa pneumonia in neutropenic and non-neutropenic hosts.
Babalola CP; Nightingale CH; Nicolau DP
J Antimicrob Chemother; 2004 Jun; 53(6):1098-100. PubMed ID: 15128727
[TBL] [Abstract][Full Text] [Related]
10. [Bone marrow aplasia associated to the use of ticlopidine].
Ruiz C; Monroy T; Montaña N; Lora P; Lamich R; Valderrama A
Rev Med Chil; 2002 Jul; 130(7):798-802. PubMed ID: 12235906
[TBL] [Abstract][Full Text] [Related]
11. [Pancytopenia caused by ticlopidine treated with filgrastim. Description of a case].
Tursi A; Modeo ME; Cuccorese G; Cascella AM; Spinazzola AM; Miglietta A
Recenti Prog Med; 2000 Oct; 91(10):511-2. PubMed ID: 11072739
[TBL] [Abstract][Full Text] [Related]
12. Cefepime-resistant Gram-negative bacteremia in febrile neutropenic patients with hematological malignancies.
Chong Y; Yakushiji H; Ito Y; Kamimura T
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e171-5. PubMed ID: 20471883
[TBL] [Abstract][Full Text] [Related]
13. The First Case of Pseudomonas aeruginosa Bacteremic Pneumonia in a Cancer Patient Receiving Pegfilgrastim.
Morita F; Hirai Y; Suzuki K; Uehara Y; Mitsuhashi K; Takahashi M; Watanabe S; Naito T
Intern Med; 2017; 56(15):2039-2042. PubMed ID: 28768977
[TBL] [Abstract][Full Text] [Related]
14. Neutropenia related to valacyclovir and valganciclovir in 2 renal transplant patients and treatment with granulocyte colony stimulating factor: a case report.
Keles M; Yildirim R; Uyanik A; Turkmen M; Bilen Y; Aydinli B; Cetinkaya R; Polat KY
Exp Clin Transplant; 2010 Jun; 8(2):181-3. PubMed ID: 20565377
[TBL] [Abstract][Full Text] [Related]
15. Prospective study of empiric monotherapy with ceftazidime for low-risk grade IV febrile neutropenia after cytotoxic chemotherapy in cancer patients.
Chernobelski P; Lavrenkov K; Rimar D; Riesenberg K; Schlaeffer F; Ariad S; Mermershtain W
Chemotherapy; 2006; 52(4):185-9. PubMed ID: 16675902
[TBL] [Abstract][Full Text] [Related]
16. Agranulocytosis associated with ticlopidine: a possible benefit with filgastim.
Marinella MA
Ann Clin Lab Sci; 1997; 27(6):418-21. PubMed ID: 9433539
[TBL] [Abstract][Full Text] [Related]
17. Ticlopidine-induced neutropenia mimicking sepsis early after intracoronary stent placement.
Ochoa AB; Wolfe M; Lewis P; Lenihan DJ
Clin Cardiol; 1998 Apr; 21(4):304-7. PubMed ID: 9562945
[TBL] [Abstract][Full Text] [Related]
18. Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: Retrospective analysis of 245 episodes.
Chatzinikolaou I; Abi-Said D; Bodey GP; Rolston KV; Tarrand JJ; Samonis G
Arch Intern Med; 2000 Feb; 160(4):501-9. PubMed ID: 10695690
[TBL] [Abstract][Full Text] [Related]
19. Community-acquired Pseudomonas aeruginosa infection in an infant.
Hendricks MK; Senekal M
Ann Trop Paediatr; 1996 Sep; 16(3):203-6. PubMed ID: 8893949
[TBL] [Abstract][Full Text] [Related]
20. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
